The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Yeo, Kiang-Teck Jerry
PropertyValue
keywords Clinical Chemistry, Pharmacogenomics, Precision Medicine, Mass Spectrometry, Cardiac Biomarkers, TDM
overview Dr. Yeo is an academic clinical chemist with over 30 years of experience and is board-certified in Clinical Chemistry (1990) & Toxicological Chemistry (1995) by the American Board of Clinical Chemistry. He was the Director of Clinical Chemistry and Endocrinology Laboratories and Dartmouth Reference Laboratory and Professor of Pathology at Dartmouth-Hitchcock Medical Center(1995-2007). Prior to that he was the Scientific Director of Clinical Chemistry and Endocrinology Laboratories and an Assistant Professor at Beth Israel Hospital and Harvard Medical School (1987-1995). Dr. Yeo was past-President of the Commission on Accreditation in Clinical Chemistry (2017-2018), past-Chair of the AACC Personalized Medicine Division (2017-2018), past Treasurer of the AACC Proteomics & Metabolomics Division (2015-2016), past-Chair of Chicago Section of AACC (2014-2015), past-Chair of the AACC Molecular Pathology Division (2008-2010), and past Vice-President of American Board of Clinical Chemistry (2003-2005). His research interests are in emerging angiogenic biomarkers, clinical mass spectrometry and clinical pharmacogenomics applications for precision medicine. He had published more than 100 original articles, book chapters and abstracts in the field of clinical chemistry and pharmacogenomics.
One or more keywords matched the following items that are connected to Yeo, Kiang-Teck Jerry
Item TypeName
Concept Biomarkers, Tumor
Concept Biomarkers
Academic Article False increase of cardiac troponin I with heterophilic antibodies.
Academic Article Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies.
Academic Article Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia?
Academic Article Elecsys NT-ProBNP and BNP assays: are there analytically and clinically relevant differences?
Academic Article Evaluation of imprecision for cardiac troponin assays at low-range concentrations.
Academic Article Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery.
Academic Article A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.
Academic Article Discrepant serum and urine ß-hCG results due to production of ß-hCG by a cribriform-morular variant of thyroid papillary carcinoma.
Academic Article Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform.
Academic Article Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension.
Academic Article Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.
Academic Article Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
Academic Article Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia.
Academic Article Real-World Use of AKI Biomarkers: A Quality Improvement Project Using Urinary Tissue Inhibitor Metalloprotease-2 and Insulin-Like Growth Factor Binding Protein 7 ([TIMP-2]*[IGFBP7]).
Academic Article Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen.
Search Criteria
  • cardiac
  • biomarker